Jianhao Li

Title: Innovations of Jianhao Li

Introduction

Jianhao Li is a prominent inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target inflammation and related diseases. With a total of 2 patents, his work is paving the way for new therapeutic options.

Latest Patents

Li's latest patents include an isoquinolinone compound for inhibiting semicarbazide-sensitive oxidase (SSAO) and vascular adhesion protein-1 (VAP-1). This compound acts as an inhibitor and is associated with a pharmaceutical composition that can be utilized to prepare drugs aimed at preventing, treating, or ameliorating inflammation and diabetes-related diseases. Notably, it is particularly effective for non-alcoholic fatty liver diseases. Another significant patent involves an amine compound that serves as an SSAO and/or VAP-1 inhibitor. This compound is also linked to a pharmaceutical composition that can be used for treating various conditions, including inflammation, diabetes, psychiatric disorders, and vascular diseases.

Career Highlights

Jianhao Li is currently associated with Sunshine Lake Pharma Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a strong focus on addressing critical health issues through scientific research and development.

Collaborations

Li collaborates with various professionals in the field, including his coworker Zheng Gu, to enhance the impact of his inventions and to drive forward the research initiatives at Sunshine Lake Pharma.

Conclusion

Jianhao Li's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to inspire advancements in the treatment of inflammation and related diseases.